JP2005514061A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514061A5 JP2005514061A5 JP2003560159A JP2003560159A JP2005514061A5 JP 2005514061 A5 JP2005514061 A5 JP 2005514061A5 JP 2003560159 A JP2003560159 A JP 2003560159A JP 2003560159 A JP2003560159 A JP 2003560159A JP 2005514061 A5 JP2005514061 A5 JP 2005514061A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34331501P | 2001-12-21 | 2001-12-21 | |
| PCT/US2002/040913 WO2003060072A2 (en) | 2001-12-21 | 2002-12-20 | Recombinant polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005514061A JP2005514061A (ja) | 2005-05-19 |
| JP2005514061A5 true JP2005514061A5 (ja) | 2005-12-22 |
| JP4660092B2 JP4660092B2 (ja) | 2011-03-30 |
Family
ID=23345581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003560159A Expired - Fee Related JP4660092B2 (ja) | 2001-12-21 | 2002-12-20 | 組換えポリペプチド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7238499B2 (ja) |
| EP (1) | EP1463755B1 (ja) |
| JP (1) | JP4660092B2 (ja) |
| AT (1) | ATE399180T1 (ja) |
| AU (1) | AU2002359780B2 (ja) |
| CA (1) | CA2470564C (ja) |
| DE (1) | DE60227285D1 (ja) |
| ES (1) | ES2309224T3 (ja) |
| MX (1) | MXPA04005909A (ja) |
| PL (1) | PL208287B1 (ja) |
| WO (1) | WO2003060072A2 (ja) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030095967A1 (en) | 1999-01-25 | 2003-05-22 | Mackay Fabienne | BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders |
| US20050100548A1 (en) * | 2001-07-24 | 2005-05-12 | Biogen Idec Ma Inc. | BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| WO2003072713A2 (en) * | 2002-02-21 | 2003-09-04 | Biogen Idec Ma Inc. | Use of bcma as an immunoregulatory agent |
| WO2004039841A2 (en) * | 2002-10-29 | 2004-05-13 | Borean Pharma A/S | Trimeric binding proteins for trimeric cytokines |
| AU2005295713B2 (en) | 2004-10-13 | 2011-06-16 | The Washington University | Use of BAFF to treat sepsis |
| DE602006007323D1 (de) * | 2005-01-28 | 2009-07-30 | Biogen Idec Inc | VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN |
| AU2011265482B2 (en) * | 2005-05-06 | 2013-08-29 | Providence Health & Services - Oregon | Trimeric OX40L-immunoglobulin fusion protein and methods of use |
| CA2606809C (en) * | 2005-05-06 | 2016-01-05 | Providence Health System | Trimeric ox40-immunoglobulin fusion protein and methods of use |
| ES2567704T3 (es) | 2007-07-10 | 2016-04-26 | Apogenix Gmbh | Proteínas de fusión de colectina de la superfamilia de TNF |
| PT3097926T (pt) * | 2007-11-01 | 2020-01-08 | Univ Guelph | Composições e métodos de potenciação das respostas imunitárias frente a eimeria |
| CN102753193A (zh) * | 2008-10-31 | 2012-10-24 | 比奥根艾迪克Ma公司 | Light靶向分子及其用途 |
| WO2013166290A1 (en) | 2012-05-04 | 2013-11-07 | Abbvie Biotherapeutics Inc. | P21 biomarker assay |
| WO2013177386A1 (en) | 2012-05-24 | 2013-11-28 | Abbvie Biotherapeutics Inc. | Biomarkers for predicting response to tweak receptor (tweakr) agonist therapy |
| DK2956165T3 (da) | 2013-02-14 | 2019-12-02 | Univ Arkansas | Sammensætninger og fremgangsmåder til forstærkning af immunreaktioner på Eimeria eller begrænsning af Eimeria-infektion |
| US10376571B2 (en) | 2013-03-15 | 2019-08-13 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to enteric pathogens |
| AU2015243562B2 (en) * | 2014-04-07 | 2019-02-28 | Lokon Pharma Ab | New medical agents and uses thereof |
| WO2017192671A1 (en) | 2016-05-03 | 2017-11-09 | The Board Of Trustees Of The University Of Arkansas | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same |
| BR112018072953A2 (pt) * | 2016-05-13 | 2019-02-19 | Medimmune, Llc | polipeptídeos de fusão de cd40l-fc e métodos de uso dos mesmos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962406A (en) * | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
| US5716805A (en) * | 1991-10-25 | 1998-02-10 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
| NZ257942A (en) * | 1992-10-23 | 1996-04-26 | Immunex Corp | Preparing a mammalian protein by expression of a fusion protein containing a leucine zipper domain |
| GB9409768D0 (en) * | 1994-05-16 | 1994-07-06 | Medical Res Council | Trimerising polypeptides |
| US7056695B2 (en) * | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
-
2002
- 2002-12-20 AT AT02794341T patent/ATE399180T1/de not_active IP Right Cessation
- 2002-12-20 EP EP02794341A patent/EP1463755B1/en not_active Expired - Lifetime
- 2002-12-20 JP JP2003560159A patent/JP4660092B2/ja not_active Expired - Fee Related
- 2002-12-20 WO PCT/US2002/040913 patent/WO2003060072A2/en active Application Filing
- 2002-12-20 US US10/326,186 patent/US7238499B2/en not_active Expired - Fee Related
- 2002-12-20 AU AU2002359780A patent/AU2002359780B2/en not_active Ceased
- 2002-12-20 CA CA2470564A patent/CA2470564C/en not_active Expired - Fee Related
- 2002-12-20 ES ES02794341T patent/ES2309224T3/es not_active Expired - Lifetime
- 2002-12-20 PL PL374266A patent/PL208287B1/pl unknown
- 2002-12-20 MX MXPA04005909A patent/MXPA04005909A/es active IP Right Grant
- 2002-12-20 DE DE60227285T patent/DE60227285D1/de not_active Expired - Lifetime